ASND
Ascendis Pharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ASND Filings
Filing Date
Form Description
Form Type
2025-12-04
Form 144 - Report of proposed sale of securities
Ownership
2025-12-04 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-02
Form 144 - Report of proposed sale of securities
Ownership
2025-12-02 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-02
Form 144 - Report of proposed sale of securities
Ownership
2025-12-02 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-02
Form 144 - Report of proposed sale of securities
Ownership
2025-12-02 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-01
Form 144 - Report of proposed sale of securities
Ownership
2025-12-01 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-26
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-26 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-12
Ascendis Pharma A/S (ASND) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-12 · Earnings Call
Ascendis Pharma A/S (ASND) Q3 2025 Earnings Call Transcript
2025-11-12
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-12 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
